全文获取类型
收费全文 | 6026篇 |
免费 | 252篇 |
国内免费 | 53篇 |
专业分类
耳鼻咽喉 | 86篇 |
儿科学 | 119篇 |
妇产科学 | 32篇 |
基础医学 | 872篇 |
口腔科学 | 155篇 |
临床医学 | 376篇 |
内科学 | 1695篇 |
皮肤病学 | 122篇 |
神经病学 | 481篇 |
特种医学 | 283篇 |
外科学 | 948篇 |
综合类 | 13篇 |
预防医学 | 153篇 |
眼科学 | 88篇 |
药学 | 286篇 |
中国医学 | 15篇 |
肿瘤学 | 607篇 |
出版年
2023年 | 47篇 |
2022年 | 68篇 |
2021年 | 108篇 |
2020年 | 54篇 |
2019年 | 82篇 |
2018年 | 98篇 |
2017年 | 90篇 |
2016年 | 99篇 |
2015年 | 149篇 |
2014年 | 193篇 |
2013年 | 256篇 |
2012年 | 334篇 |
2011年 | 345篇 |
2010年 | 196篇 |
2009年 | 182篇 |
2008年 | 309篇 |
2007年 | 388篇 |
2006年 | 415篇 |
2005年 | 370篇 |
2004年 | 411篇 |
2003年 | 382篇 |
2002年 | 431篇 |
2001年 | 74篇 |
2000年 | 53篇 |
1999年 | 93篇 |
1998年 | 93篇 |
1997年 | 91篇 |
1996年 | 85篇 |
1995年 | 80篇 |
1994年 | 77篇 |
1993年 | 69篇 |
1992年 | 60篇 |
1991年 | 55篇 |
1990年 | 46篇 |
1989年 | 35篇 |
1988年 | 25篇 |
1987年 | 35篇 |
1986年 | 25篇 |
1985年 | 21篇 |
1984年 | 28篇 |
1983年 | 23篇 |
1982年 | 30篇 |
1981年 | 36篇 |
1980年 | 21篇 |
1979年 | 13篇 |
1978年 | 20篇 |
1977年 | 17篇 |
1976年 | 19篇 |
1975年 | 20篇 |
1973年 | 13篇 |
排序方式: 共有6331条查询结果,搜索用时 15 毫秒
91.
Altered relationship between body fat and plasma adiponectin in end-stage renal disease 总被引:2,自引:0,他引:2
Shoji T Shinohara K Hatsuda S Kimoto E Fukumoto S Emoto M Tahara H Koyama H Ishimura E Miki T Tabata T Nishizawa Y 《Metabolism: clinical and experimental》2005,54(3):330-334
Patients with end-stage renal disease (ESRD) show an inverse association between body mass index and risk of death from cardiovascular disease. Paradoxical epidemiology may suggest some beneficial effects of body fat in ESRD. Because an antiatherogenic adipocytokine adiponectin is increased in uremic plasma, we tested a hypothesis that, in ESRD, plasma adipocytokine profile may be less atherogenic or that the relationship between body fat and adipocytokines may be altered. The subjects were 103 patients with ESRD undergoing hemodialysis and 166 healthy subjects comparable in age and sex. We measured body fat mass by dual-energy x-ray absorptiometry and plasma levels of adiponectin and leptin by enzyme-linked immunosorbent assay. The ESRD group showed a significant increase in plasma adiponectin, leptin, and adiponectin/leptin ratio than the healthy subjects. Although sex and fat mass were significant factors correlating with plasma adiponectin level in the healthy group, none of these were significantly associated with plasma adiponectin in the patients with ESRD. In contrast, leptin showed significant relationships with sex and fat mass regardless of the presence of ESRD. Plasma adiponectin correlated negatively with plasma triglycerides and positively with high-density lipoprotein cholesterol in both healthy and ESRD groups, suggesting that uremic adiponectin retains its actions in favor of its antiatherogenicity. Thus, plasma adipocytokine profile was altered in ESRD, and the effects of body fat and sex on adiponectin were less significant in the patients with ESRD. 相似文献
92.
Insulin alters cardiac muscle creatine kinase activity 总被引:1,自引:0,他引:1
The expression of mRNAs of creatine kinase (CK)-B and CK-M has been show to be affected by insulin, and myocardial CK-MB
activity is suppressed in insulin-deficient rats. We investigated the dose-related effect of insulin on CK-MB activity in
cardiac and skeletal muscles. Male Wistar rats were divided into three groups: (1) control group, (2) diabetic group, injected
with 65 mg/kg streptozotocin for 4 weeks, and (3) atenolol group, administered 30 mg/kg per day atenolol. Each group was further
divided into three subgroups and administered either saline, or 20 (Ins 20) or 30 (Ins 30) U/kg per day insulin. After 3 weeks,
the isoenzyme activity of CK and lactate dehydrogenase (LDH) in the left ventricle of the heart (LV) and the major pectoral
muscle (PM) was measured. Serum insulin increased and plasma glucose decreased in Ins 20 and Ins 30, dose-dependently, in
all three groups. Both CK-MB and -BB activity in LV increased dose-dependently with insulin treatment in the control, diabetes,
and atenolol groups, although these changes did not occur in skeletal muscles. CK-MB in LV correlated with the serum insulin
levels in all rats, while no correlation was found in the skeletal muscles. These findings suggest that insulin possibly regulates
the distribution of CK isoenzymes in rat heart muscle, and that the effect of insulin is not due to the sympathetic drive
induced by hypoglycemia.
Received: November 8, 1999 / Accepted: February 12, 2000 相似文献
93.
Noboru Fujino Masami Shimizu Hidekazu Ino Masato Yamaguchi Toshihiko Yasuda Mitsuru Nagata Tetsuo Konno Hiroshi Mabuchi 《The American journal of cardiology》2002,89(1):29-33
Familial hypertrophic cardiomyopathy (HC) can be caused by mutations in 9 different genes encoding sarcomere proteins expressed in cardiac muscle. To date, only 13 different mutations in the cardiac troponin T (cTnT) gene have been reported to cause HC. Clinical characteristics and prognosis associated with mutations of this gene have not been well characterized owing to the small size and composition of affected families. The aim of this study was to determine the characteristic phenotype of patients with HC caused by a novel cTnT gene mutation, Lys273Glu. Two hundred Japanese probands with HC were screened for mutations in the cTnT gene. The Lys273Glu missense mutation was present in 9 persons from 2 unrelated pedigrees. They exhibited different cardiac morphologies: 1 had a dilated cardiomyopathy-like feature, 7 had left ventricular hypertrophy with normal left ventricular systolic function, and the 6 of them had asymmetric septal hypertrophy. A 1-year-old boy was not evaluated with echocardiography. The mean maximum wall thickness was 18.0 +/- 5.5 mm (range 8 to 24). There were 7 histories of sudden death in 1 of the 2 families. The Lys273Glu substitution in the cTnT gene shows a high degree of penetrance (100% in persons aged >20 years), a high incidence of sudden death, and a partial transition from hypertrophic to dilated cardiomyopathy. Because the location of a mutation appears to influence the development of a phenotype, we suggest that the precise definition of the disease-causing mutation can provide important prognostic information about affected members. 相似文献
94.
Yoneda M Sanada H Yatabe J Midorikawa S Hashimoto S Sasaki M Katoh T Watanabe T Andrews PM Jose PA Felder RA 《Hypertension》2005,46(1):58-65
The effect of selectively decreasing renal angiotensin II type 1 (AT1) receptor expression on renal function and blood pressure has not been determined. Therefore, we studied the consequences of selective renal inhibition of AT1 receptor expression in normotensive Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR) in vivo. Vehicle, AT1 receptor antisense oligodeoxynucleotides (AS-ODN), or scrambled oligodeoxynucleotides were infused chronically into the cortex of the remaining kidney of conscious, uninephrectomized WKY and SHR on a 4% NaCl intake. Basal renal cortical membrane AT1 receptor protein was greater in SHR than in WKY. In WKY and SHR, AS-ODN decreased renal but not cardiac AT1 receptors. AT1 receptor AS-ODN treatment increased plasma renin activity to a greater extent in WKY than in SHR. However, plasma angiotensin II and aldosterone were increased by AS-ODN to a similar degree in both rat strains. In SHR, sodium excretion was increased and sodium balance was decreased by AS-ODN but had only a transient ameliorating effect on blood pressure. Urinary protein and glomerular sclerosis were markedly reduced by AS-ODN-treated SHR. In WKY, AS-ODN had no effect on sodium excretion, blood pressure, or renal histology but also modestly decreased proteinuria. The major consequence of decreasing renal AT1 receptor protein in the SHR is a decrease in proteinuria, probably as a result of the amelioration in glomerular pathology but independent of systemic blood pressure and circulating angiotensin II levels. 相似文献
95.
Expression of GPIV and Naka antigen on monocytes in Naka -negative subjects whose platelets lack GPIV
Hironori Take Hirokazu Kashiwagi Yoshiaki Tomiyama Shigenori Honda Yumiko Honda Hajime Mizutani Takayasu Furubayashi Takahiro Karasuno Tetsuo Nishiura Yoshio Kanayama Yoshiyuki Kurata Yuji Matsuzawa 《British journal of haematology》1993,84(3):387-391
Summary. The platelet antigen Naka was once considered to be a platelet-specific alloantigen and is carried on platelet membrane glycoprotein (GP) IV. Recent studies suggest that Naka -negative subjects lack platelet GPIV. GPIV is an important adhesive receptor and expressed on the surface of monocytes as well as of platelets. In the present study, flow cytometry was used to detect GPIV and Naka antigen on the surface of monocytes. Naka antigen was expressed on monocytes as well as on platelets in Naka -positive subjects ( n = 6) (P-GPIV-positive subjects). To our surprise, monocytes of Naka -negative subjects ( n = 7) (P-GPIV-negative subjects) having no anti-Naka antibody in their serum expressed GPIV and Naka antigen to almost the same degree as did the monocytes of P-GPIV-positive subjects. Competitive experiments using OKM5 (a monoclonal antibody against GPIV) and anti-Naka antibody showed that the epitope of anti-Naka antibody on monocytes was very close to that of OKM5. In two P-GPIV-negative subjects having anti-Naka antibody in their serum, GPIV and Naka antigen were not expressed on the surface of either monocytes or platelets. These results indicate that the GPIV molecules and Naka antigen are expressed on the surface of monocytes in the majority of P-GPIV-negative subjects, but that in a very few P-GPIV-negative subjects neither GPIV nor Naka antigen is expressed on the surface of their monocytes. We hypothesize that P-GPIV-negative subjects who carry neither GPIV nor Naka antigen on their monocytes produce anti-Naka antibody as a result of transfusion or pregnancy. 相似文献
96.
Taka-Aki Matsuyama Shin Inoue Kaoru Tanno Mutsuki Makino Genyo Ogawa Tetsuo Sakai Youichi Kobayashi Takashi Katagiri Hidekazu Ota 《Europace : European pacing, arrhythmias, and cardiac electrophysiology》2006,8(11):977-979
We report a case, which we believe to be rare, of adenosine-sensitive atrial tachycardia (AT) originating from the mitral valve annulus. The patient, a 73-year-old woman, died of unrelated cause 4 years after radiofrequency (RF) ablation therapy. Histologically, fibrous replacement of atrial musculature by mature collagenous tissue produced by the RF current was observed at the left inferior atrioventricular junction. In serial sections that included the coronary sinus, two distinct nodal structures containing small, pale myocytes within the fibrous tissue matrix were identified around the region of the ablation lesion. Our case appears to be a unique representation of tissue that was associated with the occurrence and maintenance of AT. 相似文献
97.
Ryoji Kobayashi Shosuke Sunami Tetsuo Mitsui Atsuko Nakazawa Yuhki Koga Takeshi Mori Fumiko Tanaka Jun‐ichi Ueyama Tomoo Osumi Reiji Fukano Kentaro Ohki Masahiro Sekimizu Tetsuya Mori Lymphoma Committee Japanese Pediatric Leukemia/Lymphoma Study Group 《Pediatrics international》2015,57(4):523-534
Results of pediatric lymphoma treatment have improved markedly over the past 30 years. In Hodgkin's lymphoma, the 5 year event‐free survival (EFS) was 81.5% in a retrospective study. In the ALB‐NHL03 study, the 5 year EFS according to clinical stage in patients with lymphoblastic T‐cell lymphoma (T‐LBL) was 70.6% for stage III and 88.9% for stage IV. In mature B‐cell lymphoma, the B‐NHL03 study indicated that the 4 year EFS according to treatment group was 94% for group 1, 98% for group 2, 84% for group 3, and 78% for group 4. Moreover, the 2 year EFS rate was 81% in Japanese advanced stage patients based on the international ALCL99 study. Thus, EFS >80% was achieved in any subtype of pediatric lymphoma. With regard to refractory or recurrent lymphoma, however, treatment methods for improvement of the survival rate in these patients still need to be developed. Also the difference between child, and adolescent and young adult patients still needs to be clarified, and treatment protocols developed. Although lymphoma treatment does not greatly change according to country, it does differ between other countries and Japan for some subtypes of lymphoma. In particular, the results of treatment of stage III T‐LBL in Japan are worse than those in the USA and Europe. The priority in future studies will be to collect data on these differences, and the reasons for these differences. 相似文献
98.
Oshitani N Matsumura Y Kono M Tamori A Higuchi K Matsumoto T Seki S Arakawa T 《Digestive diseases and sciences》2002,47(12):2711-2714
Phlebosclerosis of the mesenteric vein is a rare condition causing chronic intestinal ischemia, it has only been reported in Japan. A 56-year-old man with liver cirrhosis and hepatic tumor presented with phlebosclerosis of mesenteric vein without any abdominal symptoms. He was admitted for examination of suspected hepatic tumor. Abdominal plain x-ray films and computed tomography revealed calcification of the mesenteric vein. Barium enema revealed narrowing and thumbprinting from the cecum to transverse colon. On colonoscopic examination, blue-black vessels were visible in the terminal ileum, and hyperemic nodular mucosa with small irregular ulcers surrounded by dark purple mucosa was found from the cecum to transverse colon. The etiology of mesenteric vein phlebosclerosis is unknown, although a physical mechanism rather than inflammatory changes appear to be involved in this rare and usually progressive condition of chronic intestinal ischemia. 相似文献
99.
Nobuyoshi Kawakita Shuichi Seki Hiroki Sakaguchi Atsushi Yanai Kazuki Nakatani Takao Yamada Takuya Kitada Yasuhiko Sakai Tetsuo Kuroki Kenzo Kobayashi Takeyuki Monna 《Liver international》1994,14(6):295-301
ABSTRACT: The retinoblastoma gene product is a nuclear phosphoprotein that undergoes cell cycle-dependent changes in its phosphorylation status. To analyze the expression of retinoblastoma gene product in the process of liver regeneration and the initiation of hepatocellular carcinoma, we studied immunohistochemically the expression of retinoblastoma gene product and DNA polymerase alpha (DPA) in 33 patients with various liver diseases. Only a few hepatocytes positive for retinoblastoma gene product were found in undamaged, nonregenerating liver tissues, whereas many hepatocytes positive for retinoblastoma gene product were detected in specimens of regenerating liver obtained from patients with acute or chronic liver diseases. Similarities were found between distribution patterns of hepatocytes positive for retinoblastoma gene product and those of hepatocytes positive for DPA, and a highly significant positive correlation was found between the number of hepatocyte nuclei stained for retinoblastoma gene product per 1000 nuclei examined (R-LI) and the number of hepatocyte nuclei stained for DPA per 1000 nuclei examined (D-LI) in tissues obtained from patients with nonmalignant liver disease. Hepatocellular carcinoma cells positive for DPA were detected in the 14 hepatocellular carcinoma specimens tested. In ten of these specimens, hepatocellular carcinoma cells positive for retinoblastoma gene product were found but not in the other four. For all hepatocellular carcinoma specimens, R-LI was proportional to D-LI. Thus in both nonmalignant and malignant liver, retinoblastoma gene product increased in proportion to proliferation of hepatocytes or hepatocellular carcinoma cells. 相似文献
100.